home / stock / ecor / ecor quote
Last: | $6.2501 |
---|---|
Change Percent: | 0.0% |
Open: | $6.25 |
Close: | $6.2501 |
High: | $6.32 |
Low: | $6.16 |
Volume: | 1,621 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$6.2501 | $6.25 | $6.2501 | $6.32 | $6.16 | 1,621 | 07-04-2024 |
$6.2501 | $6.25 | $6.2501 | $6.32 | $6.16 | 1,621 | 07-03-2024 |
$6.32 | $6.2901 | $6.32 | $6.3775 | $6.2901 | 1,879 | 07-02-2024 |
$6.43 | $6.28 | $6.43 | $6.43 | $6.28 | 2,856 | 07-01-2024 |
$6.43 | $6.35 | $6.43 | $6.6 | $6.07 | 11,658 | 06-28-2024 |
$6.44 | $6.24 | $6.44 | $6.44 | $6.15 | 11,166 | 06-27-2024 |
$6.32 | $6.08 | $6.32 | $6.32 | $6.0544 | 6,798 | 06-26-2024 |
$6.15 | $6.26 | $6.15 | $6.32 | $6.15 | 7,991 | 06-25-2024 |
$6.22 | $6.31 | $6.22 | $6.3504 | $6.2 | 6,802 | 06-24-2024 |
$6.28 | $6 | $6.28 | $6.28 | $5.9101 | 15,493 | 06-21-2024 |
$6.11 | $5.8 | $6.11 | $6.17 | $5.8 | 29,414 | 06-20-2024 |
$5.77 | $6.255 | $5.77 | $6.2751 | $5.77 | 20,761 | 06-19-2024 |
$5.77 | $6.255 | $5.77 | $6.2751 | $5.77 | 20,761 | 06-18-2024 |
$6.27 | $6.1 | $6.27 | $6.36 | $6.1 | 6,479 | 06-17-2024 |
$6.16 | $6.1875 | $6.16 | $6.32 | $6.04 | 4,461 | 06-14-2024 |
$6.34 | $6.42 | $6.34 | $6.44 | $6.34 | 5,502 | 06-13-2024 |
$6.51 | $6.59 | $6.51 | $6.6 | $6.42 | 4,324 | 06-12-2024 |
$6.6 | $6.49 | $6.6 | $6.6631 | $6.42 | 2,969 | 06-11-2024 |
$6.43 | $6.43 | $6.43 | $6.43 | $6.43 | 1,394 | 06-10-2024 |
$6.55 | $6.43 | $6.55 | $6.68 | $6.43 | 3,091 | 06-07-2024 |
News, Short Squeeze, Breakout and More Instantly...
ROCKAWAY, N.J., June 25, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, is thrilled to announce the Commercial Off the Shelf (COTS) availability of the next generation TAC-STIM™, a non-invasive vagus nerve stimulat...
2024-06-11 04:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
ROCKAWAY, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a commercial-stage bioelectronic medicine and wellness company, today announced the closing of its previously announced registered direct offering of 22...